Gastrointestinal Transit Time Assessed Using a <scp>CT</scp>‐Based Radiopaque Marker Method in Patients With Acute Pancreatitis During Methylnaltrexone Treatment
Our CT-based method was feasible in hospitalized patients with AP. Methylnaltrexone did not change gastrointestinal transit compared with placebo. However, laxative therapy was more frequent with the placebo.
Authors
- Cecilie Siggaard Knoph (ORCID: https://orcid.org/0000-0002-8373-1487)
- Srdan Novovic (ORCID: https://orcid.org/0000-0001-6246-874X)
- Søren Schou Olesen (ORCID: https://orcid.org/0000-0003-3916-3168)
- M Hansen (ORCID: https://orcid.org/0000-0003-1305-3382)
- Irene Maria Høgsberg
- Jens Brøndum Frøkjær (ORCID: https://orcid.org/0000-0001-8722-0070)
- Asbjørn Mohr Drewes (ORCID: https://orcid.org/0000-0001-7465-964X)
- Michael Bau Mortensen (ORCID: https://orcid.org/0000-0002-7270-5005)
- Esben Bolvig Mark (ORCID: https://orcid.org/0000-0002-4176-7430)
- Mathias Ellgaard Cook (ORCID: https://orcid.org/0000-0002-4157-1091)
- Liv Bjerre Juul Nielsen (ORCID: https://orcid.org/0000-0002-2255-6507)
- Ole Thorlacius‐Ussing (ORCID: https://orcid.org/0000-0003-4963-1551)
- Celina Salomon
- Andreas Svenstrup Hesthaven
Institutions
- University of Copenhagen (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Bispebjerg Hospital (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Mech-Sense (DK)
- Svendborg Sygehus (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1111/nmo.70027
- Citations
- 1
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Novo Nordisk
- Novo Nordisk Fonden